Celularity Stock Buy Hold or Sell Recommendation
| CELU Stock | USD 1.55 0.01 0.65% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Celularity is 'Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Celularity given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Celularity, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Celularity Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide. Note, we conduct extensive research on individual companies such as Celularity and provide practical buy, sell, or hold advice based on investors' constraints. Celularity. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Celularity |
Execute Celularity Buy or Sell Advice
The Celularity recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Celularity. Macroaxis does not own or have any residual interests in Celularity or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Celularity's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Very Weak | Details | |
Volatility | Extremely Dangerous | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Celularity Trading Alerts and Improvement Suggestions
| Celularity generated a negative expected return over the last 90 days | |
| Celularity has high historical volatility and very poor performance | |
| Celularity may become a speculative penny stock | |
| Celularity has a very high chance of going through financial distress in the upcoming years | |
| Celularity currently holds 65.42 M in liabilities with Debt to Equity (D/E) ratio of 0.41, which is about average as compared to similar companies. Celularity has a current ratio of 0.89, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Celularity's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 22.77 M. Net Loss for the year was (196.29 M) with profit before overhead, payroll, taxes, and interest of 30.95 M. | |
| Celularity currently holds about 42.65 M in cash with (38.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.29. | |
| Roughly 56.0% of Celularity shares are held by company insiders | |
| Latest headline from thelincolnianonline.com: Celularity Enters Strategic Collaboration Agreement with BlueSphere Bio to Support Cell Therapy Manufacturing |
Celularity Returns Distribution Density
The distribution of Celularity's historical returns is an attempt to chart the uncertainty of Celularity's future price movements. The chart of the probability distribution of Celularity daily returns describes the distribution of returns around its average expected value. We use Celularity price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Celularity returns is essential to provide solid investment advice for Celularity.
| Mean Return | -0.38 | Value At Risk | -9.37 | Potential Upside | 9.04 | Standard Deviation | 7.46 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Celularity historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Celularity Stock Institutional Investors
The Celularity's institutional investors refer to entities that pool money to purchase Celularity's securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Centerstar Asset Management, Llc | 2024-12-31 | 22 K | Ipg Investment Advisors, Llc | 2024-12-31 | 17.2 K | Renaissance Technologies Corp | 2024-12-31 | 11 K | Ground Swell Capital, Llc | 2024-12-31 | 10.5 K | Bank Of America Corp | 2024-12-31 | 2.3 K | Simplex Trading, Llc | 2024-12-31 | 1.5 K | Ubs Group Ag | 2024-12-31 | 1.2 K | Ifp Advisors, Llc | 2024-12-31 | 1000 | Corecap Advisors, Llc | 2024-12-31 | 500 | C V Starr & Co Inc | 764.1 K | Vanguard Group Inc | 2024-12-31 | 500.1 K |
Celularity Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (643K) | (6.4M) | (16.9M) | (865K) | (778.5K) | (817.4K) | |
| Change In Cash | 26.0M | (17.4M) | (23.3M) | (18.6M) | (16.8M) | (15.9M) | |
| Depreciation | 8.2M | 8.8M | 9.4M | 9.3M | 10.7M | 8.8M | |
| Capital Expenditures | 27.8M | 6.2M | 5.2M | 4.0M | 3.6M | 3.5M | |
| Net Income | (208.2M) | (100.1M) | 14.2M | (196.3M) | (176.7M) | (167.8M) | |
| End Period Cash Flow | 69.5M | 52.1M | 28.8M | 10.2M | 11.7M | 11.1M | |
| Investments | (137.5K) | (5.9M) | (5.2M) | (4.0M) | (4.7M) | (4.9M) | |
| Free Cash Flow | (91.0M) | (116.3M) | (143.1M) | (42.7M) | (49.1M) | (51.6M) | |
| Other Non Cash Items | 137.4M | (46.4M) | (159.4M) | (92.3M) | 130.0M | 136.5M |
Celularity Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Celularity or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Celularity's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Celularity stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.17 | |
β | Beta against Dow Jones | 2.02 | |
σ | Overall volatility | 7.73 | |
Ir | Information ratio | -0.04 |
Celularity Volatility Alert
Celularity is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Celularity's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Celularity's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Celularity Fundamentals Vs Peers
Comparing Celularity's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Celularity's direct or indirect competition across all of the common fundamentals between Celularity and the related equities. This way, we can detect undervalued stocks with similar characteristics as Celularity or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Celularity's fundamental indicators could also be used in its relative valuation, which is a method of valuing Celularity by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Celularity to competition |
| Fundamentals | Celularity | Peer Average |
| Return On Equity | -1.47 | -0.31 |
| Return On Asset | -0.17 | -0.14 |
| Profit Margin | (0.73) % | (1.27) % |
| Operating Margin | (1.24) % | (5.51) % |
| Current Valuation | 105.83 M | 16.62 B |
| Shares Outstanding | 23.81 M | 571.82 M |
| Shares Owned By Insiders | 56.26 % | 10.09 % |
| Shares Owned By Institutions | 15.00 % | 39.21 % |
| Number Of Shares Shorted | 287.43 K | 4.71 M |
| Price To Earning | 3.08 X | 28.72 X |
| Price To Book | 2.14 X | 9.51 X |
| Price To Sales | 0.77 X | 11.42 X |
| Revenue | 22.77 M | 9.43 B |
| Gross Profit | 30.95 M | 27.38 B |
| EBITDA | (183.95 M) | 3.9 B |
| Net Income | (196.29 M) | 570.98 M |
| Cash And Equivalents | 42.65 M | 2.7 B |
| Cash Per Share | 0.29 X | 5.01 X |
| Total Debt | 65.42 M | 5.32 B |
| Debt To Equity | 0.41 % | 48.70 % |
| Current Ratio | 0.91 X | 2.16 X |
| Book Value Per Share | 0.79 X | 1.93 K |
| Cash Flow From Operations | (38.69 M) | 971.22 M |
| Short Ratio | 5.08 X | 4.00 X |
| Earnings Per Share | (100.39) X | 3.12 X |
| Target Price | 2.5 | |
| Number Of Employees | 120 | 18.84 K |
| Beta | 0.76 | -0.15 |
| Market Capitalization | 36.9 M | 19.03 B |
| Total Asset | 143.89 M | 29.47 B |
| Retained Earnings | (841.79 M) | 9.33 B |
| Working Capital | (47.51 M) | 1.48 B |
| Net Asset | 143.89 M |
Note: Disposition of 10000 shares by Brigido Stephen of Celularity subject to Rule 16b-3 [view details]
Celularity Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Celularity . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Celularity Buy or Sell Advice
When is the right time to buy or sell Celularity? Buying financial instruments such as Celularity Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Celularity in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Impulse Thematic Idea Now
Impulse
Large corporations operating in retail, broadcasting, energy, airlines and telecom sectors. The Impulse theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Impulse Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Celularity Stock Analysis
When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.